GROUP ONE TRADING, L.P. - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is and the CUSIP is 45826J905. A total of 4 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$784,176
-28.2%
24,800
-7.5%
0.00%
-25.0%
Q2 2023$1,092,904
-59.4%
26,800
-62.9%
0.00%
-60.0%
Q1 2023$2,694,621
-41.1%
72,300
-44.9%
0.01%
-9.1%
Q4 2022$4,574,079
-21.0%
131,100
+26.7%
0.01%0.0%
Q3 2022$5,792,000
+113.6%
103,500
+97.5%
0.01%
+175.0%
Q2 2022$2,712,000
+4.8%
52,400
+47.2%
0.00%
+33.3%
Q1 2022$2,587,000
-50.4%
35,600
-19.3%
0.00%
-25.0%
Q4 2021$5,214,000
-19.0%
44,100
-8.1%
0.00%
-42.9%
Q3 2021$6,439,000
-76.2%
48,000
-71.2%
0.01%
-78.8%
Q2 2021$27,023,000
+277.5%
166,900
+87.1%
0.03%
+200.0%
Q1 2021$7,159,000
+1726.3%
89,200
+1138.9%
0.01%
+1000.0%
Q4 2020$392,000
-15.3%
7,200
-69.1%
0.00%0.0%
Q3 2020$463,000
-42.6%
23,300
-39.3%
0.00%
-75.0%
Q2 2020$807,000
+341.0%
38,400
+156.0%
0.00%
+300.0%
Q1 2020$183,000
-56.9%
15,000
-48.3%
0.00%
-66.7%
Q4 2019$425,000
+123.7%
29,000
+104.2%
0.00%
+50.0%
Q3 2019$190,000
-15.2%
14,200
+3.6%
0.00%0.0%
Q2 2019$224,000
-52.1%
13,700
-50.0%
0.00%
-60.0%
Q1 2019$468,000
+22.8%
27,400
-1.8%
0.01%
+66.7%
Q4 2018$381,000
+29.2%
27,900
+170.9%
0.00%
+50.0%
Q3 2018$295,000
-70.9%
10,300
-72.2%
0.00%
-77.8%
Q2 2018$1,015,000
+154.4%
37,100
+96.3%
0.01%
+125.0%
Q1 2018$399,000
-49.5%
18,900
-54.0%
0.00%
-33.3%
Q4 2017$790,000
+926.0%
41,100
+1225.8%
0.01%
+500.0%
Q3 2017$77,000
+1183.3%
3,100
+675.0%
0.00%
Q2 2017$6,000
-95.1%
400
-95.4%
0.00%
-100.0%
Q1 2017$123,0008,7000.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
PURA VIDA INVESTMENTS, LLC 50,000$2,588,0000.15%
GROUP ONE TRADING, L.P. 52,400$2,712,0000.00%
JANE STREET GROUP, LLC 48,000$2,484,0000.00%
SIMPLEX TRADING, LLC 9,200$476,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of INTELLIA THERAPEUTICS INC shareholders